Diez-Domingo J - Search Results

1

Economic evaluation of meningococcal vaccines: considerations for the future.

Christensen H, Al-Janabi H, Levy P, Postma MJ, Bloom DE, Landa P, Damm O, Salisbury DM, Diez-Domingo J, Towse AK, Lorgelly PK, Shah KK, Hernandez-Villafuerte K, Smith V, Glennie L, Wright C, York L, Farkouh R. Christensen H, et al. Eur J Health Econ. 2020 Mar;21(2):297-309. doi: 10.1007/s10198-019-01129-z. Epub 2019 Nov 21. Eur J Health Econ. 2020. PMID: 31754924 Free PMC article.

2

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents.

Vesikari T, Østergaard L, Diez-Domingo J, Wysocki J, Flodmark CE, Beeslaar J, Eiden J, Jiang Q, Jansen KU, Jones TR, Harris SL, O'Neill RE, York LJ, Crowther G, Perez JL. Vesikari T, et al. J Pediatric Infect Dis Soc. 2016 Jun;5(2):152-60. doi: 10.1093/jpids/piv039. Epub 2015 Aug 4. J Pediatric Infect Dis Soc. 2016. PMID: 26407272 Free PMC article. Clinical Trial.

3

Adverse events after polysaccharide meningococcal A&C vaccine.

Díez-Domingo J, Albert A, Valdivieso C, Ballester A, Díez LV, Morant A. Díez-Domingo J, et al. Scand J Infect Dis. 1998;30(6):636-8. doi: 10.1080/00365549850161331. Scand J Infect Dis. 1998. PMID: 10225406

4

Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine.

Pereiró I, Díez-Domingo J, Morant A, Gimeno C, Lerma M, San-Martín M, González A; Group for the Study of Invasive Diseases. Pereiró I, et al. Scand J Infect Dis. 2001;33(8):581-4. doi: 10.1080/00365540110026638. Scand J Infect Dis. 2001. PMID: 11525350

5

Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain).

Pérez-Breva L, Villanueva RJ, Villanueva-Oller J, Acedo L, Santonja F, Moraño JA, Abad R, Vázquez JA, Díez-Domingo J. Pérez-Breva L, et al. BMC Infect Dis. 2014 May 21;14:280. doi: 10.1186/1471-2334-14-280. BMC Infect Dis. 2014. PMID: 24886054 Free PMC article.

6

From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain.

Crépey P, Redondo E, Díez-Domingo J, Ortiz de Lejarazu R, Martinón-Torres F, Gil de Miguel Á, López-Belmonte JL, Alvarez FP, Bricout H, Solozabal M. Crépey P, et al. PLoS One. 2020 May 21;15(5):e0233526. doi: 10.1371/journal.pone.0233526. eCollection 2020. PLoS One. 2020. PMID: 32437476 Free PMC article.

7

Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).

Díez-Domingo J, Ridao-López M, Gutiérrez-Gimeno MV, Puig-Barberá J, Lluch-Rodrigo JA, Pastor-Villalba E. Díez-Domingo J, et al. Vaccine. 2011 Dec 6;29(52):9640-8. doi: 10.1016/j.vaccine.2011.10.038. Epub 2011 Oct 24. Vaccine. 2011. PMID: 22027484

8

A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants.

Martinon-Torres F, Gimenez-Sanchez F, Bernaola-Iturbe E, Diez-Domingo J, Jiang Q, Perez JL. Martinon-Torres F, et al. Vaccine. 2014 Sep 8;32(40):5206-11. doi: 10.1016/j.vaccine.2014.07.049. Epub 2014 Jul 29. Vaccine. 2014. PMID: 25077420 Free article. Clinical Trial.

9

Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age.

Snape MD, Voysey M, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Kieninger D, Prymula R, Dull PM, Kohl I, Barone M, Wang H, Toneatto D, Pollard AJ; European MenB Vaccine Study Group. Snape MD, et al. Pediatr Infect Dis J. 2016 Apr;35(4):e113-23. doi: 10.1097/INF.0000000000001056. Pediatr Infect Dis J. 2016. PMID: 26756390 Clinical Trial.

10

Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination.

Pérez-Breva L, Abad-Torreblanca R, Martínez-Beneito MÁ, Puig-Barberà J, Alemán-Sánchez S, Morant-Talamante N, Sastre-Cantón M, Vázquez-Moreno JA, Díez-Domingo J. Pérez-Breva L, et al. Vaccine. 2017 May 19;35(22):2949-2954. doi: 10.1016/j.vaccine.2017.04.022. Epub 2017 Apr 21. Vaccine. 2017. PMID: 28438407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page